Unknown

Dataset Information

FTO mediates the diabetic kidney disease progression through regulating the m<sup>6</sup>A modification of NLRP3.


ABSTRACT:

Background

The objective of our research was to investigate the specific mechanism of FTO in diabetic kidney disease (DKD) progression.

Methods

The DKD model was established with renal tubular epithelial HK-2 cells and mice in vitro and in vivo. The N6-methyladenosine (m6A) content in cells was detected using dot plot assay and the m6A levels of NLRP3 was detected with the MeRIP assay. The mRNA and protein levels were tested with real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) and western blot. The IL-1β and IL-18 levels were assessed with enzyme-linked immunosorbent assay (ELISA). The cell viability was measured by cell counting kit (CCK)-8 assay and cell pyroptosis was determined with Annexin V and propidium iodide (PI) double stai

SUBMITTER: Li Q 

PROVIDER: S-EPMC11468296 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature